Expression of concern--effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
- PMID: 23561987
- DOI: 10.1016/S0140-6736(13)60778-3
Expression of concern--effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
Comment in
-
Under-reporting of adverse effects of tesofensine.Lancet. 2013 Jul 13;382(9887):127. doi: 10.1016/S0140-6736(13)61563-9. Lancet. 2013. PMID: 23849924 No abstract available.
Comment on
-
Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.Lancet. 2008 Nov 29;372(9653):1906-1913. doi: 10.1016/S0140-6736(08)61525-1. Epub 2008 Oct 22. Lancet. 2008. PMID: 18950853 Clinical Trial.
Expression of concern for
-
Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.Lancet. 2008 Nov 29;372(9653):1906-1913. doi: 10.1016/S0140-6736(08)61525-1. Epub 2008 Oct 22. Lancet. 2008. PMID: 18950853 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
